We are a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together.

We aim to positively impact the health of 2.5 billion people over the next 10 years. Our bold ambitions for patients are refelected in new commitments to growth and a step-change in performance.

GSK in oncology is focused on maximising patient survival through transformational medicines.